NO992531L - Fremgangsmåter ved fremstilling av rekombinant protein - Google Patents

Fremgangsmåter ved fremstilling av rekombinant protein

Info

Publication number
NO992531L
NO992531L NO992531A NO992531A NO992531L NO 992531 L NO992531 L NO 992531L NO 992531 A NO992531 A NO 992531A NO 992531 A NO992531 A NO 992531A NO 992531 L NO992531 L NO 992531L
Authority
NO
Norway
Prior art keywords
methods
producing recombinant
recombinant protein
proteins
relates
Prior art date
Application number
NO992531A
Other languages
English (en)
Norwegian (no)
Other versions
NO992531D0 (no
Inventor
Pradip Mukerji
Robert George Hards
Jennifer Marie Thurmond
Amanda Eun-Yeong Leonard
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO992531D0 publication Critical patent/NO992531D0/no
Publication of NO992531L publication Critical patent/NO992531L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
NO992531A 1996-11-27 1999-05-26 Fremgangsmåter ved fremstilling av rekombinant protein NO992531L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/757,177 US6071718A (en) 1996-11-27 1996-11-27 Methods of producing a recombinant protein
PCT/US1997/022095 WO1998023762A2 (en) 1996-11-27 1997-11-24 Methods of producing a recombinant protein

Publications (2)

Publication Number Publication Date
NO992531D0 NO992531D0 (no) 1999-05-26
NO992531L true NO992531L (no) 1999-07-27

Family

ID=25046717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992531A NO992531L (no) 1996-11-27 1999-05-26 Fremgangsmåter ved fremstilling av rekombinant protein

Country Status (6)

Country Link
US (1) US6071718A (de)
EP (1) EP0941347A2 (de)
JP (1) JP2001506489A (de)
CA (1) CA2272988A1 (de)
NO (1) NO992531L (de)
WO (1) WO1998023762A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287866B1 (en) * 1996-11-27 2001-09-11 Abbott Laboratories β-casein expressing constructs
KR100369839B1 (ko) * 1997-02-28 2003-06-12 주식회사 엘지생명과학 바실러스리케니포미스균주에서유래한아미노펩티다제,그의제조방법및이를이용한천연형단백질의제조방법
US7109015B2 (en) * 2004-03-29 2006-09-19 Academia Sinica Removal of N-terminal methionine from proteins by engineered methionine aminopeptidase
KR102949308B1 (ko) * 2020-03-16 2026-04-06 피나 바이오솔루션스, 엘엘씨 용해성 재조합 단백질의 생산
EP4627072A1 (de) 2022-11-29 2025-10-08 Unichem Laboratories Limited Proteine mit minimalem n-terminalem initiator-methionin
SE2430062A1 (en) 2024-02-08 2025-08-09 Cassius Ab Efficient production of recombinant casein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60184A (en) * 1979-05-31 1984-05-31 Schering Ag Process for the specific cleavage of protein sequences from proteins
US5013662A (en) * 1985-09-20 1991-05-07 Cetus Corporation Bacterial methionine n-terminal peptidase
DE3822045A1 (de) * 1988-06-30 1990-01-11 Hoechst Ag Verfahren zur herstellung von proteinen
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
NZ304538A (en) * 1995-02-27 1999-08-30 Abbott Lab Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein

Also Published As

Publication number Publication date
NO992531D0 (no) 1999-05-26
EP0941347A2 (de) 1999-09-15
WO1998023762A3 (en) 1998-10-29
CA2272988A1 (en) 1998-06-04
JP2001506489A (ja) 2001-05-22
US6071718A (en) 2000-06-06
WO1998023762A2 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
IL161016A0 (en) Specific binding agents of human angiopoietin-2
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
IL124831A0 (en) Ob protein derivatives having prolonged half-life
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
MXPA02004666A (es) Gelatinas recombinantes.
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
NO20006191L (no) Vaksine
SE8902532L (sv) Bestaemning av plasmaproteiner
DE122007000031I1 (de) Für menschliches Papillomavirus stamm 18 kodierende DNS
IL187595A0 (en) Antitumor antibodies, proteins, and uses thereof
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
DE69836333D1 (de) Neisseria lactoferrin-bindendes protein
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
EP1443055A3 (de) Interleukine-21 und 22
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
SE9604439D0 (sv) New receptor
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ES2191785T3 (es) Proteina de accion antitumoral.
TW200635953A (en) Specific binding agents of human angiopoietin-2
WO1998056810A3 (de) Humanes protein lus-i, seine herstellung und verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application